日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Successful postcoital testing of Ovaprene: An investigational non-hormonal monthly vaginal contraceptive

Ovaprene 的性交后测试成功:一种在研的非激素性每月阴道避孕药

Mauck, Christine; Thurman, Andrea; Jensen, Jeffrey T; Schreiber, Courtney A; Baker, Jeff; Hou, Melody Y; Chavoustie, Steven; Dart, Clint; Wu, Hongsheng; Zack, Nadene; Hatheway, Jessica; Friend, David

A phase 1/2, open-label, parallel group study to evaluate the safety and pharmacokinetics of DARE-HRT1 (80 μg estradiol/4 mg progesterone and 160 μg estradiol/8 mg progesterone intravaginal rings) over 12 weeks in healthy postmenopausal women

一项 1/2 期、开放标签、平行组研究,旨在评估 DARE-HRT1(80 μg 雌二醇/4 mg 孕酮和 160 μg 雌二醇/8 mg 孕酮阴道环)在健康绝经后妇女中 12 周的安全性和药代动力学。

Thurman, Andrea; Hull, M Louise; Stuckey, Bronwyn; Hatheway, Jessica; Zack, Nadene; Mauck, Christine; Friend, David

A phase 1/2, open-label, parallel group study to evaluate the preliminary efficacy and usability DARE-HRT1 (80 μg estradiol/4 mg progesterone and 160 μg estradiol/8 mg progesterone intravaginal RinGSM) over 12 weeks in healthy postmenopausal women

一项 1/2 期、开放标签、平行组研究,旨在评估 DARE-HRT1(80 μg 雌二醇/4 mg 孕酮和 160 μg 雌二醇/8 mg 孕酮阴道内 RinGSM)在健康绝经后妇女中 12 周的初步疗效和可用性。

Thurman, Andrea; Hull, M Louise; Stuckey, Bronwyn; Hatheway, Jessica; Zack, Nadene; Mauck, Christine; Friend, David

A Phase 1 pharmacokinetic study of a single-dose bioadhesive clindamycin 2% gel for bacterial vaginosis

一项针对细菌性阴道炎的单剂量2%生物粘附性克林霉素凝胶的I期药代动力学研究

Mauck, Christine K; Atiee, George J; McCulloh, Jennifer; Reynolds, Laurie; Zack, Nadene; Friend, David R

The postcoital test in the development of new vaginal contraceptives†

阴道避孕药研发中的性交后试验†

Mauck, Christine K; Vincent, Kathleen L

Use of contraceptive depot medroxyprogesterone acetate is associated with impaired cervicovaginal mucosal integrity

使用醋酸甲羟孕酮缓释剂避孕与宫颈阴道黏膜完整性受损有关。

Zalenskaya, Irina A; Chandra, Neelima; Yousefieh, Nazita; Fang, Xi; Adedipe, Oluwatosin E; Jackson, Suzanne S; Anderson, Sharon M; Mauck, Christine K; Schwartz, Jill L; Thurman, Andrea R; Doncel, Gustavo F

Assessment of the vaginal residence time of biomarkers of semen exposure

评估精液暴露生物标志物在阴道内的停留时间

Thurman, Andrea; Jacot, Terry; Melendez, Johan; Kimble, Thomas; Snead, Margaret; Jamshidi, Roxanne; Wheeless, Angie; Archer, David F; Doncel, Gustavo F; Mauck, Christine

Biomarkers of Cervical Inflammation and Immunity Associated with Cervical Shedding of HIV-1.

与宫颈HIV-1病毒脱落相关的宫颈炎症和免疫生物标志物

Mauck Christine, Chen Pai-Lien, Morrison Charles S, Fichorova Raina N, Kwok Cynthia, Chipato Tsungai, Salata Robert A, Doncel Gustavo F

The Contribution of Cervicovaginal Infections to the Immunomodulatory Effects of Hormonal Contraception.

宫颈阴道感染对激素避孕免疫调节作用的影响

Fichorova Raina N, Chen Pai-Lien, Morrison Charles S, Doncel Gustavo F, Mendonca Kevin, Kwok Cynthia, Chipato Tsungai, Salata Robert, Mauck Christine

A Phase 1 Randomized, Open Label, Rectal Safety, Acceptability, Pharmacokinetic, and Pharmacodynamic Study of Three Formulations of Tenofovir 1% Gel (the CHARM-01 Study)

一项针对三种 1% 替诺福韦凝胶制剂的 1 期随机、开放标签、直肠安全性、可接受性、药代动力学和药效学研究(CHARM-01 研究)

Mcgowan, Ian; Cranston, Ross D; Duffill, Kathryn; Siegel, Aaron; Engstrom, Jarret C; Nikiforov, Alexyi; Jacobson, Cindy; Rehman, Khaja K; Elliott, Julie; Khanukhova, Elena; Abebe, Kaleab; Mauck, Christine; Spiegel, Hans M L; Dezzutti, Charlene S; Rohan, Lisa C; Marzinke, Mark A; Hiruy, Hiwot; Hendrix, Craig W; Richardson-Harman, Nicola; Anton, Peter A